Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership

Affiliations

• ¹ Centre for Cardiovascular Innovation, St Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada; Centre for Heart Valve Innovation, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: [email protected].
• ² University of California, San Diego Sulpizio Cardiovascular Center, La Jolla, California.
• ³ Department of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, Georgia.
• ⁴ Centre for Cardiovascular Innovation, St Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada; Centre for Heart Valve Innovation, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
• ⁵ Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
• ⁶ Brown University School of Medicine, Providence, Rhode Island.
• ⁷ Department of Medicine, Stanford University, Stanford, California.
• ⁸ Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
• ⁹ Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina.
• ¹⁰ Cooper Medical School of Rowan University, Camden, New Jersey.
• ¹¹ Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
• ¹² Northwestern University Feinberg School of Medicine, Chicago, Illinois.
• ¹³ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Children's Hospital Boston/Harvard Medical School, Boston, Massachusetts.
• ¹⁴ Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
• ¹⁵ New Brunswick Heart Centre, Dalhousie University, Saint John, New Brunswick, Canada.